Gastroenterologists’ Urgency in Treating Celiac Disease Increases as the Number of Viable Pipeline Candidates Dwindles, According to Spherix Global Insights – QNT Press Release

The recent loss of the only Phase 3 CeD pipeline candidate highlights the unmet need of suitable treatments for a patient population seeking alternatives to the gluten-free diet

EXTON, Pa., Aug. 8, 2022 /PRNewswire/ — Spherix recently surveyed 100 US gastroenterologists and conducted eight qualitative interviews to assess the current and future management of celiac disease (CeD). The combination of both qualitative and quantitative research included in the Market Dynamix™: Celiac Disease (US) service evaluates the diagnostic and treatment trends emerging with the condition, as well as physician reactions to potential therapies in development.

The 2022 report reveals a greater sense of urgency from gastroenterologists compared to the general sentiment found in last year’s report. Indeed, nearly three-quarters of respondents in the 2022 survey say that their CeD patient load has increased in the …

Full story available on

Source link

Recommended For You

About the Author: News Center